Enterovirus 71 infection

Clinical trials for Enterovirus 71 infection explained in plain language.

Never miss a new study

Get alerted when new Enterovirus 71 infection trials appear

Sign up with your email to follow new studies for Enterovirus 71 infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a vaccine shield children from severe hand, foot, and mouth disease?

Vaccine Not yet recruiting

This trial tests an inactivated EV71 vaccine in healthy children aged 6 to 71 months. The vaccine targets enterovirus 71, a major cause of severe hand, foot, and mouth disease in the Asia-Pacific region. Each child receives two doses, 30 days apart. Researchers measure whether th…

Matched conditions: ENTEROVIRUS 71 INFECTION

Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine

Last updated Sep 03, 2026 00:00 UTC

Enterovirus 71 infection

Get alerted when new Enterovirus 71 infection trials appear

Can a vaccine shield children from severe hand, foot, and mouth disease?